MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.

Acute myeloid leukemia (AML) is as a highly aggressive and heterogeneous hematological malignancy. MiR-20a-5p has been reported to function as an oncogene or tumor suppressor in several tumors, but the clinical significance and regulatory mechanisms of miR-20a-5p in AML cells have not been fully und...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fengchang Bao, Lei Zhang, Xiaohang Pei, Cheng Lian, Yanhui Liu, Hongna Tan, Pingchong Lei
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0c417fb8567e4269b36a5b936c5ea5d7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c417fb8567e4269b36a5b936c5ea5d7
record_format dspace
spelling oai:doaj.org-article:0c417fb8567e4269b36a5b936c5ea5d72021-12-02T20:14:03ZMiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.1932-620310.1371/journal.pone.0256995https://doaj.org/article/0c417fb8567e4269b36a5b936c5ea5d72021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256995https://doaj.org/toc/1932-6203Acute myeloid leukemia (AML) is as a highly aggressive and heterogeneous hematological malignancy. MiR-20a-5p has been reported to function as an oncogene or tumor suppressor in several tumors, but the clinical significance and regulatory mechanisms of miR-20a-5p in AML cells have not been fully understood. In this study, we found miR-20a-5p was significantly decreased in bone marrow from AML patients, compared with that in healthy controls. Moreover, decreased miR-20a-5p expression was correlated with risk status and poor survival prognosis in AML patients. Overexpression of miR-20a-5p suppressed cell proliferation, induced cell cycle G0/G1 phase arrest and apoptosis in two AML cell lines (THP-1 and U937) using CCK-8 assay and flow cytometry analysis. Moreover, miR-20a-5p overexpression attenuated tumor growth in vivo by performing tumor xenograft experiments. Luciferase reporter assay and western blot demonstrated that protein phosphatase 6 catalytic subunit (PPP6C) as a target gene of miR-20a-5p was negatively regulated by miR-20a-5p in AML cells. Furthermore, PPP6C knockdown imitated, while overexpression reversed the effects of miR-20a-5p overexpression on AML cell proliferation, cell cycle G1/S transition and apoptosis. Taken together, our findings demonstrate that miR-20a-5p/PPP6C represent a new therapeutic target for AML and a potential diagnostic marker for AML therapy.Fengchang BaoLei ZhangXiaohang PeiCheng LianYanhui LiuHongna TanPingchong LeiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0256995 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fengchang Bao
Lei Zhang
Xiaohang Pei
Cheng Lian
Yanhui Liu
Hongna Tan
Pingchong Lei
MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
description Acute myeloid leukemia (AML) is as a highly aggressive and heterogeneous hematological malignancy. MiR-20a-5p has been reported to function as an oncogene or tumor suppressor in several tumors, but the clinical significance and regulatory mechanisms of miR-20a-5p in AML cells have not been fully understood. In this study, we found miR-20a-5p was significantly decreased in bone marrow from AML patients, compared with that in healthy controls. Moreover, decreased miR-20a-5p expression was correlated with risk status and poor survival prognosis in AML patients. Overexpression of miR-20a-5p suppressed cell proliferation, induced cell cycle G0/G1 phase arrest and apoptosis in two AML cell lines (THP-1 and U937) using CCK-8 assay and flow cytometry analysis. Moreover, miR-20a-5p overexpression attenuated tumor growth in vivo by performing tumor xenograft experiments. Luciferase reporter assay and western blot demonstrated that protein phosphatase 6 catalytic subunit (PPP6C) as a target gene of miR-20a-5p was negatively regulated by miR-20a-5p in AML cells. Furthermore, PPP6C knockdown imitated, while overexpression reversed the effects of miR-20a-5p overexpression on AML cell proliferation, cell cycle G1/S transition and apoptosis. Taken together, our findings demonstrate that miR-20a-5p/PPP6C represent a new therapeutic target for AML and a potential diagnostic marker for AML therapy.
format article
author Fengchang Bao
Lei Zhang
Xiaohang Pei
Cheng Lian
Yanhui Liu
Hongna Tan
Pingchong Lei
author_facet Fengchang Bao
Lei Zhang
Xiaohang Pei
Cheng Lian
Yanhui Liu
Hongna Tan
Pingchong Lei
author_sort Fengchang Bao
title MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
title_short MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
title_full MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
title_fullStr MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
title_full_unstemmed MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
title_sort mir-20a-5p functions as a potent tumor suppressor by targeting ppp6c in acute myeloid leukemia.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/0c417fb8567e4269b36a5b936c5ea5d7
work_keys_str_mv AT fengchangbao mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT leizhang mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT xiaohangpei mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT chenglian mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT yanhuiliu mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT hongnatan mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
AT pingchonglei mir20a5pfunctionsasapotenttumorsuppressorbytargetingppp6cinacutemyeloidleukemia
_version_ 1718374687960989696